Nordic ListingsIssuer Report
Scandinavian ChemoTech AB: Quarterly Trading Report 2025 Q3
Scandinavian ChemoTech AB: Quarterly Trading Report 2025 Q3https://view.news.eu.nasdaq.com/view?id=b09514f2a2e631f4ebbc486f38d99a5e6&lang=en&src=omxlink
Scandinavian ChemoTech AB: Quarterly Trading Report 2025 Q3
Scandinavian ChemoTech AB on 6ix
Earlier from Scandinavian ChemoTech
- ChemoTech's Animal Care Reports Strong Q3 Sales, Surpassing Expectations Despite Seasonal Slowdown
- Chemotech's Animal Care Enters Swiss Market As Part Of DACH Expansion
- CMOTEC_B: Animal Care sales hit records and TSE tech achieved scientific validation, fueling growth
- CMOTEC_B: Animal Care sales surged and global reach expanded, but funding needs remain
- CMOTEC_B: 2024 saw record sales, improved results, and strong Animal Care growth, supporting future expansion
Later from Scandinavian ChemoTech
- CMOTEC_B: Strong Q3 revenue growth and record Animal Care sales drive improved financials and outlook
- Chemotech's Animal Care Announces First U.S. Order
- CMOTEC_B: Revenue doubled and losses narrowed, with Animal Care driving growth and US expansion
- Scandinavian ChemoTech (Q4 Review): Seasonal softness, intact growth case
- Sweden's ChemoTech Q1 net sales rise, loss narrows on US operation improvement
Follow Scandinavian ChemoTech into a list and get an email when it puts out news.
Follow Scandinavian ChemoTech